Blue Water Life Science Advisors, LP Exact Sciences Corp Transaction History
Blue Water Life Science Advisors, LP
- $114 Million
- Q3 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 255,243 shares of EXAS stock, worth $14.1 Million. This represents 15.28% of its overall portfolio holdings.
Number of Shares
255,243
Previous 57,343
345.12%
Holding current value
$14.1 Million
Previous $2.42 Million
617.55%
% of portfolio
15.28%
Previous 2.36%
Shares
5 transactions
Others Institutions Holding EXAS
# of Institutions
670Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$979 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$873 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$790 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$665 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$368 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.76B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...